Research indicates that interfering with specific brain receptors, namely nociceptin/orphanin FQ (N/OFQ) and NOP, might reduce nicotine-seeking behavior. This could lead to new treatments for nicotine dependence.
Both genetic and drug-based methods to block these receptors have shown promise in animal studies, suggesting a potential pathway for developing effective smoking cessation therapies.